Full metadata record
DC Field | Value | Language |
---|---|---|
dc.creator | Morales-Lozano, M. I. (Mª Isabel) | - |
dc.creator | Viering, O. (Oliver) | - |
dc.creator | Samnick, S. (Samuel) | - |
dc.creator | Rodriguez-Otero, P. (Paula) | - |
dc.creator | Buck, A.K. (Andreas K.) | - |
dc.creator | Marcos-Jubilar, M. (María) | - |
dc.creator | Rasche, L. (Leo) | - |
dc.creator | Prieto, E. (Elena) | - |
dc.creator | Kortüm, K.M. (K. Martin) | - |
dc.creator | San-Miguel, J.F. (Jesús F.) | - |
dc.creator | Garcia-Velloso, M. J. (María José) | - |
dc.creator | Lapa, C. (Constantin) | - |
dc.date.accessioned | 2023-05-17T07:11:18Z | - |
dc.date.available | 2023-05-17T07:11:18Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Morales-Lozano, M. I. (Mª Isabel); Viering, O. (Oliver); Samnick, S. (Samuel); et al. "18F-FDG and 11C-Methionine PET/CT in Newly Diagnosed Multiple Myeloma Patients: Comparison of Volume-Based PET Biomarkers". Cancers. 12 (4), 2020,1042 | es_ES |
dc.identifier.uri | https://hdl.handle.net/10171/66272 | - |
dc.description.abstract | 11C-methionine (11C-MET) is a new positron emission tomography (PET) tracer for the assessment of disease activity in multiple myeloma (MM) patients, with preliminary data suggesting higher sensitivity and specificity than 18F-fluorodeoxyglucose (18F-FDG). However, the value of tumor burden biomarkers has yet to be investigated. Our goals were to corroborate the superiority of 11C-MET for MM staging and to compare its suitability for the assessment of metabolic tumor burden biomarkers in comparison to 18F-FDG. Twenty-two patients with newly diagnosed, treatment-naïve symptomatic MM who had undergone 11C-MET and 18F-FDG PET/CT were evaluated. Standardized uptake values (SUV) were determined and compared with total metabolic tumor volume (TMTV) for both tracers: total lesion glycolysis (TLG) and total lesion 11C-MET uptake (TLMU). PET-derived values were compared to Revised International Staging System (R-ISS), cytogenetic, and serologic MM markers such as M component, beta 2 microglobulin (B2M), serum free light chains (FLC), albumin, and lactate dehydrogenase (LDH). In 11 patients (50%), 11C-MET detected more focal lesions (FL) than FDG (p < 0.01). SUVmax, SUVmean, SUVpeak, TMTV, and TLMU were also significantly higher in 11C-MET than in 18F-FDG (p < 0.05, respectively). 11C-MET PET biomarkers had a better correlation with tumor burden (bone marrow plasma cell infiltration, M component; p < 0.05 versus p = n.s. respectively). This pilot study suggests that 11C-MET PET/CT is a more sensitive marker for the assessment of myeloma tumor burden than 18F-FDG. Its implications for prognosis evaluation need further investigation. | es_ES |
dc.description.sponsorship | This research was funded by the Ministry of Economy and Competitiveness (PI 16/00225), the Ministry of Science and Innovation, Government of Spain (grant no. ADE 10/00028) and the Wilhelm Sander-Stiftung (grant 2017.061.1). | es_ES |
dc.language.iso | eng | es_ES |
dc.relation | info:eu-repo/grantAgreement/MINECO/Proyectos de investigación en salud (Modalidad Proyectos de investigación en salud) (AE Salud 2016)/PI16%2F00225/ES/Evaluación de 18F-FDG, 11C-MET y 11C-COL para la detección de infiltración tumoral en Mieloma Múltiple (MM): Estudio traslacional en modelos preclínico y clínico en pacientes (MIELOMAPET) | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.subject | Multiple myeloma | es_ES |
dc.subject | Methionine | es_ES |
dc.subject | Total lesion glycolysis (TLG) | es_ES |
dc.subject | Metabolic tumor volume (MTV) | es_ES |
dc.subject | Total lesion methionine uptake (TLMU) | es_ES |
dc.title | 18F-FDG and 11C-Methionine PET/CT in Newly Diagnosed Multiple Myeloma Patients: Comparison of Volume-Based PET Biomarkers | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.description.note | This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). | es_ES |
dc.identifier.doi | 10.3390/cancers12041042 | - |
dadun.citation.number | 4 | es_ES |
dadun.citation.publicationName | Cancers | es_ES |
dadun.citation.startingPage | 1042 | es_ES |
dadun.citation.volume | 12 | es_ES |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.